Use of Carbapenems, Polymyxins, and Tigecycline in United States Children’s Hospitals, 2010–2014

<span class="paragraphSection"><div class="boxTitle">Abstract</div>We characterized use of the carbapenems, polymyxins, and tigecycline in United States children’s hospitals between 2010 and 2014. We found substantial variability in use across hospitals and overall decreased use over time. Most polymyxin and tigecycline use occurred in cystic fibrosis patients, and appendectomy was a common indication for carbapenem therapy.</span>

from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2qLergF
via IFTTT